BridgeBio Pharma annual operating margin
2019
2020
2021
2022
2023
2024
2025
BridgeBio Pharma Operating Margin Growth & History (BBIO)
BridgeBio Pharma's operating margin was −104.25% for fiscal 2025.
View full BridgeBio Pharma company overviewBridgeBio Pharma annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −104.25% | +162.97 pp |
| 2024 | 2024-12-31 | −267.22% | +6261.53 pp |
| 2023 | 2023-12-31 | −6,528.75% | −5869.11 pp |
| 2022 | 2022-12-31 | −659.65% | +167.47 pp |
| 2021 | 2021-12-31 | −827.12% | +4924.88 pp |
| 2020 | 2020-12-31 | −5,751.99% | −5095.58 pp |
| 2019 | 2019-12-31 | −656.41% | — |
BridgeBio Pharma quarterly operating margin
Q3.19
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −43.94% | +77.50 pp |
| Q1 2026 | 2026-03-31 | −54.47% | +35.02 pp |
| Q4 2025 | 2025-12-31 | −90.52% | +3752.17 pp |
| Q3 2025 | 2025-09-30 | −120.30% | +6898.37 pp |
| Q2 2025 | 2025-06-30 | −121.45% | +7975.37 pp |
| Q1 2025 | 2025-03-31 | −89.49% | −89.65 pp |
| Q4 2024 | 2024-12-31 | −3,842.69% | +6324.42 pp |
| Q3 2024 | 2024-09-30 | −7,018.67% | −3164.06 pp |
| Q2 2024 | 2024-06-30 | −8,096.82% | +806.23 pp |
| Q1 2024 | 2024-03-31 | 0.16% | +6909.42 pp |
| Q4 2023 | 2023-12-31 | −10,167.11% | −3256.30 pp |
| Q3 2023 | 2023-09-30 | −3,854.61% | +34345.39 pp |
| Q2 2023 | 2023-06-30 | −8,903.05% | −8794.33 pp |
| Q1 2023 | 2023-03-31 | −6,909.26% | +3343.28 pp |
| Q4 2022 | 2022-12-31 | −6,910.80% | −5625.58 pp |
| Q3 2022 | 2022-09-30 | −38,200.00% | −31822.06 pp |
| Q2 2022 | 2022-06-30 | −108.72% | +65.31 pp |
| Q1 2022 | 2022-03-31 | −10,252.54% | +26003.74 pp |
| Q4 2021 | 2021-12-31 | −1,285.22% | +190.58 pp |
| Q3 2021 | 2021-09-30 | −6,377.94% | −6174.02 pp |
| Q2 2021 | 2021-06-30 | −174.02% | — |
| Q1 2021 | 2021-03-31 | −36,256.28% | — |
| Q3 2020 | 2020-09-30 | −1,475.81% | — |
| Q3 2019 | 2019-09-30 | −203.93% | — |
BridgeBio Pharma operating margin trends
Over the last five reported fiscal years, BridgeBio Pharma's operating margin increased from −5,751.99% to −104.25%, a change of +5647.74 percentage points. The latest reported quarter, Q2 2026, shows −43.94%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BridgeBio Pharma filings at SEC.gov ↗